The World Anti-Doping Agency (WADA) has given a clean-chit to the process adopted in the case of India opener Prithvi Shaw and two other cricketers. Last month, the BCCI banned the trio for a doping violation. The Indian board had banned Shaw, Akshay Dullarwar and Divya Gajraj for six to eight months on July 30.
In the wake of the bans dished out to the players, there were questions raised over the procedure of dope testing and imposition of punishment. WADA had later stated that it would take a look into the entire process. On Thursday, the world agency said the process did not breach any WADA code. WADA also stated that there would not be an appeal against the punishments.
“Following a thorough review of the three cases that included advice from external legal counsel, WADA has concluded that all the decisions are in line with the World Anti-Doping Code. As such, we will not be lodging an appeal,” the WADA said as quoted by Bangalore Mirror.
Shaw, who has played two Tests so far, accepted the verdict of the BCCI after confessing to having taken cough syrup which contained banned Terbutaline. The BCCI had said it was satisfied with Shaw’s explanation.
The board stated that Shaw had inadvertently ingested a prohibited substance which can be commonly found in cough syrups. The Mumbai star had provided a urine sample as part of the BCCI’s anti-doping testing program during the Syed Mushtaq Ali Trophy match on 22nd February 2019 in Indore. His sample was subsequently tested and found to contain Terbutaline. Later reports suggested that the youngster has left the country to take a break and overcome a depression.
Meanwhile, days after Shaw was banned, the BCCI agreed to come under the ambit of the National Anti-Doping Agency (NADA).